ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2211

What Are the Consequences of Spinal Ankylosis on the Bone Trabecular Fragility Assessed on CT- scan in Patients with Ankylosing Spondylitis?

Marine Fauny1, Caroline Morizot 1, Edem Allado 1, Frank VERHOEVEN 2, Eliane Albuisson 3, Astrid Pinzano-Watrin 4, Isabelle Chary-Valckenaere 3 and Damien Loeuille 5, 1CHRU Nancy, VANDOEUVRE, France, 2CHU Besancon, BESANCON, France, 3Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, 4IMoPA. UMR 7365 CNRS, Vandoeuvre, France, 5Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ankylosing spondylitis (AS), modified stoke ankylosing spondylitis spinal score (MSASSS) and bone density, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Computed Tomography (CT) is sometimes performed during the follow up of patients with ankylosing spondylitis (AS) to screen comorbidities or complications. Thoracic or thoraco-abdomino-pelvic (TAP) CT have demonstrated their ability to depict vertebral fracture and recently to assess trabecular bone fragility though the scanographic bone attenuation coefficient (SBAC) on lumbar vertebrae (L1 to L5). To your knowledge, no study has assessed the impact of partial or complete vertebra ankylosis on the trabecular bone.

The principal objective was to characterize the SBAC on normal lumbar spine or spine with partial or total ankylosis.

Methods: This monocentric retrospective study included patients with AS followed from 2009 to 2017 at Nancy university hospital, fulfilling New-York criteria for AS and who underwent a thoracic or TAP CT and X-rays (spine, pelvis) within 2 years. Clinical characteristics were collected. Modified stoke ankylosing spondylitis spinal score (mSASSS) was scored by two readers, adjudication for one syndesmophyte discordance. Presence of one syndesmophyte defined mSASSS+ (mSASSS ≥ 2). Moreover, each lumbar vertebra was studied according to its level of ankylosis, 0: no lesion, 1: syndesmophyte(s), 2: partial ankylosis (superior or inferior) and 3: total ankylosis (both inferior and superior). The SBAC was measured in Hounsfield Units (HU) on L1 to L5 vertebrae, and a fracture threshold was defined at ≤145 HU.

Results: On 1503 spondyloarthritits, 73 AS patients were included (mean age: 60.3 (±10.7) years, 8 women (11%)). Sixty patients (82.2%) had a mSASSS ≥ 2, with a mean score of 20.7 (±21.2).  Presence of ankylosis of at least one disco-vertebral unit in cervical or lumbar segments of the spine on mSASSS was observed in 37 patients (50.7%) and 6 (8.2%) have total lumbar spine ankylosis. Concerning the lumbar spine, the details of number of vertebrae without structural lesion, with syndesmophyte(s) or with partial and complete ankylosis are presented in table 1. The SBAC for each lumbar vertebra were not significantly different between patients with mSASSS < 2 versus mSASSS ≥ 2 (p = 0.24 to 0.99). However, the SBAC was lower for patients with mSASSS≥ 2 and bone bridge than for patients with mSASSS≥ 2 without bone bridge (p = 0.02 to 0.0001). The risk of SBAC ≤ 145 HU was higher in presence of total ankylosis on at least one lumbar vertebra (HR: 4.95(CI95% :1.104-17.36, p = 0.04 to 0.001)). Partial lumbar ankylosis of L3 and L4 affected also the SBAC with higher risk to have a SBAC ≤145 HU (HR :11.8 (CI95% :1.822-25.67) and 15 (CI95%: 2.54-30.85)) respectively.

Conclusion: Only AS patients with ankylosed vertebra on mSASSS presented lower values of SBAC. We showed that complete ankylosis of any lumbar vertebra and partial ankylosis of L3 and L4 were associated with lower values of SBAC, suggesting deterioration of the trabecular bone structure ankylosed.


ACR Article 2 Abstract Table VF


Disclosure: M. Fauny, None; C. Morizot, None; E. Allado, None; F. VERHOEVEN, None; E. Albuisson, None; A. Pinzano-Watrin, None; I. Chary-Valckenaere, None; D. Loeuille, None.

To cite this abstract in AMA style:

Fauny M, Morizot C, Allado E, VERHOEVEN F, Albuisson E, Pinzano-Watrin A, Chary-Valckenaere I, Loeuille D. What Are the Consequences of Spinal Ankylosis on the Bone Trabecular Fragility Assessed on CT- scan in Patients with Ankylosing Spondylitis? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/what-are-the-consequences-of-spinal-ankylosis-on-the-bone-trabecular-fragility-assessed-on-ct-scan-in-patients-with-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-are-the-consequences-of-spinal-ankylosis-on-the-bone-trabecular-fragility-assessed-on-ct-scan-in-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology